Cutaneous Manifestations of Antiphospholipid Antibody Syndrome

Hematology/Oncology Clinics of North America

Volumn 22, Issue 1, 2008, Pages 67-77

  Weinstein, Sari ^a   Piette, Warren ^a,b  

^a Jr Hospital of Cook County   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DIPYRIDAMOLE; ETHYLESTRENOL; FIBRINOLYTIC AGENT; HEPARIN; IMMUNOGLOBULIN; METFORMIN; PENTOXIFYLLINE; PHENFORMIN; PHOSPHOLIPID ANTIBODY; STEROID;

ANETODERMA; ANTIPHOSPHOLIPID SYNDROME; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; LIVEDO RETICULARIS; MALIGNANT ATROPHIC PAPULOSIS; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN BIOPSY; SKIN MANIFESTATION; SNEDDON SYNDROME; VASCULAR DISEASE;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; HUMANS; SKIN DISEASES, VASCULAR;

EID: 38349058090     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2007.10.011     Document Type: Review

References (31)

1. Uthman I., and Khamashta M. Livedo racemosa: a striking dermatological sign for the antiphospholipid syndrome. J Rheumatol 33 12 (2006) 2379-2382
2. Miyakis S., Lockshin M., Atsumi T., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 (2005) 295-306
3. Frances C., Niang S., Laffitte E., et al. Dermatologic manifestations of the antiphospholipid syndrome. Arthritis Rheum 52 (2005) 1785-1790
4. Zelger B., Sepp N., Stockhammer G., et al. Sneddon's syndrome: long-term follow-up of 21 patients. Arch Dermatol 129 (1993) 437-447
5. Gibbs M., English J., and Zirwas M. Livedo reticularis: an update. J Am Acad Dermatol 52 6 (2005) 1009-1019
6. Sneddon I. Cerebro-vascular lesions and livedo reticularis. Br J Dermatol 77 (1965) 180-185
7. Frances C., and Piette J.C. The mystery of Sneddon syndrome: relationship with antiphospholipid syndrome and systemic lupus erythematosus. J Autoimmun 15 2 (2000) 139-143
8. Erkan D., Harrison M.J., Levy R., et al. Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis Rheum 56 7 (2007) 2383-2391
9. Acland K.M., Darvay A., Wakelin S.H., et al. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome?. Br J Dermatol 140 1 (1999) 131-135
10. Hairston B., Davis M., Pittelkow M., et al. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Arch Dermatol 142 (2006) 1413-1418
11. Piette W. Cutaneous manifestations of microvascular occlusion syndromes. In: Bolognia J., Jorrizo J., and Rapini R. (Eds). Dermatology. 1st edition (2003), Mosby, London 2003
12. Shornick J., Nicholes B., Bergstresser P., et al. Idiopathic atrophie blanche. J Am Acad Dermatol 8 6 (1983) 792-798
13. Klein K., and Pittelkow M. Tissue plasminogen activator for treatment of livedoid vasculitis. Mayo Clin Proc 67 (1992) 923-933
14. Petri M. Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis. Lupus 5 Suppl 1 (1996) S16-S22
15. Katz S., Mudd L., and Roenigk H. Malignant atrophic papulosis (Degos' disease) involving three generations of a family. J Am Acad Dermatol 37 (1997) 480-484
16. Gibson G., Su W., and Pittelkow M. Antiphospholipid syndrome and the skin. J Am Acad Dermatol 36 (1997) 970-982
17. Harvell J., Williford P., and White W. Benign cutaneous Degos' disease: a case report with emphasis on histopathology as papules chronologically evolve. Am J Dermatopathol 23 2 (2001) 116-123
18. Robson K., and Piette W. The presentation and differential diagnosis of cutaneous vascular occlusion syndromes. Adv Dermatol 15 6 (1999) 153-182
19. Asherson R.A., Frances C., Iaccarino L., et al. The antiphospholipid antibody syndrome: diagnosis, skin manifestations, and current therapy. Clin Exp Rheumatol 24 Suppl 40 (2006) S46-S51
20. Piette W. Purpura and coagulation. In: Bolognia J., Jorrizo J., and Rapini R. (Eds). Dermatology. 1st edition (2003), Mosby, London 355-363
21. Asherson R. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome. Immunobiology 210 10 (2005) 727-733
22. Cervera R., Piette J.C., Font J., et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46 4 (2002) 1019-1027
23. Rossini J., Roverano S., Graf C., et al. Widespread cutaneous necrosis associated with antiphospholipid antibodies: report of four cases. J Clin Rheumatol 8 6 (2002) 326-331
24. Pascual J., Gimenez E., Sivera F., et al. Atrophic macules and papules in a 24-year-old woman. Arch Dermatol 143 (2007) 109-114
25. Sparsa A., Piette J.C., Weschsler B., et al. Anetoderma and its prothrombotic abnormalities. J Am Acad Dermatol 49 6 (2003) 1008-1012
26. Hodak E., Shamai-Lubovitz O., David M., et al. Immunologic abnormalities associated with primary anetoderma. Arch Dermatol 128 6 (1992) 799-803
27. Disdier P., Harle J., Andrac L., et al. Primary anetoderma associated with the antiphospholipid syndrome. J Am Acad Dermatol 30 (1994) 133-134
28. de Souza E., Christofoletti P., and Cintra M. Anetoderma associated with primary antiphospholipid syndrome. J Am Acad Dermatol 56 5 (2007) 881-882
29. Venhoff N., Miehle N., Juttner E., et al. Clinical images: anetoderma in systemic lupus erythematosus with antiphospholipid antibodies. Arthritis Rheum 52 7 (2005) 365-380
30. Bilen N., Bayramgurler D., Sikar A., et al. Anetoderma associated with antiphospholipid syndrome and systemic lupus erythematosus. Lupus 12 9 (2003) 714-716
31. Romani J., Perez F., Llobet M., et al. Anetoderma associated with the antiphospholipid antibodies: case report and review of the literature. J Eur Acad Dermatol Venereol 15 2 (2001) 175-178